United States · Biotechnology startup
United States · Scribe Therapeutics
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Funding reportedLast round: Convertible note
What company datasets say Scribe Therapeutics raised
Funding, as reported
Reported in all$120Min dollars
Rounds3
Last roundConvertible note
Last round dateMay 2023
Investors listed10
SEC Form D$100M sold, 1 filing, last Apr 2021
Founders and team
From the SEC filings it signed: 1 on the team.
- Benjamin OakesExecutive Officer, Directori
On the board, as filediBehzad AghazadehCarl GordonVijay Pande
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Scribe Therapeutics in front of investors. Or tell us what we have wrong.